Timothy F. Goggins

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.4K citations · Full text

Medicine, Endocrinology, Oncology +17

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Medicine, Oncology, Breast Oncology +16

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin et al. · New England Journal of Medicine · 2019 · 555 citations · Full text

Medicine, Oncology, Breast Oncology +16

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · JAMA Oncology · 2019 · 168 citations · Full text

Medicine, Endocrinology, Oncology +16

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

Kathy S. Albain, Robert J. Gray, Della Makower et al. · JNCI Journal of the National Cancer Institute · 2020 · 114 citations · Full text

Medicine, Oncology, Breast Oncology +16